Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Polymethyl methacrylate (PMMA) microspheres are non-biodegradable, biologically inert synthetic polymer particles used primarily in aesthetic medicine as a permanent dermal filler. Typically measuring 30-40 micrometers in diameter, these microspheres are often suspended in a carrier medium, such as bovine atelo-collagen, to facilitate injection. Upon implantation, the microspheres provide immediate volume and subsequently act as a scaffold that stimulates endogenous collagen deposition (neocollagenesis) by the body's fibroblasts. This dual action results in long-lasting tissue augmentation and wrinkle correction. Originally developed as Artecoll and later refined as Artefill (now Bellafill), PMMA microspheres are FDA-approved for the correction of nasolabial folds and moderate-to-severe acne scars. Beyond aesthetics, PMMA has a long history of use in orthopedics as bone cement.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on polymethyl methacrylate microspheres.